QTREX Quantum Valuation Multiples

QTREX Quantum is valued at $58M as of September 2026, a 191.5x revenue multiple. In the last FY QTREX Quantum reported revenue of $289K and EBITDA of ($13M).

QTREX Quantum Overview

About QTREX Quantum

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.


Founded

2018

HQ

Israel

Employees

47

Financials (LTM)

Revenue: $289K
EBITDA: ($11M)

EV

$55M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

QTREX Quantum Financials

QTREX Quantum reported last 12-month revenue of $289K and negative EBITDA of ($11M).

In the same LTM period, QTREX Quantum generated $2K in gross profit, ($11M) in EBITDA losses, and had net loss of ($13M).

Revenue (LTM)


QTREX Quantum P&L

In the most recent fiscal year, QTREX Quantum reported revenue of $289K and EBITDA of ($13M).

QTREX Quantum is unprofitable as of last fiscal year, with gross margin of 1%, EBITDA margin of (4441%), and net margin of (4574%).

See analyst estimates for QTREX Quantum
LTMLast FY2025202620272028
Revenue$289K$289K$289K
Gross Profit$2K$2K$2K
Gross Margin1%1%1%
EBITDA($11M)($13M)($13M)
EBITDA Margin(3709%)(4441%)(4441%)
EBIT Margin(4714%)(4714%)(4714%)
Net Profit($13M)($13M)($13M)
Net Margin(4574%)(4574%)(4574%)
Net Debt-($3M)-

Financial data powered by Morningstar, Inc.

QTREX Quantum Stock Performance

QTREX Quantum has current market cap of $58M, and enterprise value of $55M.

Market Cap Evolution


QTREX Quantum's stock price is $0.87.

QTREX Quantum share price decreased by 31.9% in the last year.

QTREX Quantum has an EPS (earnings per share) of $-0.20.

See more trading valuation data for QTREX Quantum
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$55M$58M5.2%---31.9%$-0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

QTREX Quantum Valuation Multiples

QTREX Quantum trades at 191.5x EV/Revenue multiple, and (5.2x) EV/EBITDA.

See NTM and 2027E valuation multiples for QTREX Quantum

EV / Revenue (LTM)


QTREX Quantum Financial Valuation Multiples

As of September 18, 2026, QTREX Quantum has market cap of $58M and EV of $55M.

QTREX Quantum has a P/E ratio of (4.4x).

LTMLast FY2025202620272028
EV/Revenue191.5x191.5x191.5x
EV/EBITDA(5.2x)(4.3x)(4.3x)
EV/EBIT(4.1x)(4.1x)(4.1x)
EV/Gross Profitn/mn/mn/m
P/E(4.4x)(4.4x)(4.4x)
EV/FCF-(5.6x)(5.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified QTREX Quantum Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

QTREX Quantum Margins & Growth Rates

QTREX Quantum grew revenue by 16509% but EBITDA decreased by 154% in the last fiscal year.

In the most recent fiscal year, QTREX Quantum reported gross margin of 1%, EBITDA margin of (4441%), and net margin of (4574%).

See estimated margins and future growth rates for QTREX Quantum

QTREX Quantum Margins

Last FY20252026202720282029
Gross Margin1%1%40%
EBITDA Margin(4441%)(4441%)14%
EBIT Margin(4714%)(4714%)9%
Net Margin(4574%)(4574%)9%
FCF Margin(3448%)(3448%)-

QTREX Quantum Growth Rates

FY+1/FY25/2626/2727/2828/29
Revenue Growth16509%16509%
Gross Profit Growth959900%959900%
EBITDA Growth(154%)(154%)
EBIT Growth(130%)(130%)
Net Profit Growth(133%)(133%)

Data powered by FactSet, Inc. and Morningstar, Inc.

QTREX Quantum Operational KPIs

QTREX Quantum's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.

QTREX Quantum's Rule of 40 is 16523% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

QTREX Quantum's Rule of X is 41287% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for QTREX Quantum
LTMLast FY2025202620272028
Rule of 4012800%16523%-
Bessemer Rule of X37563%41287%-
Revenue per Employee-$0.0M-
Opex per Employee-$0.3M-
S&M Expenses to Revenue203%32%32%
G&A Expenses to Revenue1914%52%52%
R&D Expenses to Revenue2594%2594%2594%
Opex to Revenue-4715%4715%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

QTREX Quantum Competitors

QTREX Quantum competitors include TELA Bio, Outset Medical, Pangaea Oncology, Theraclion, K Pharma, Bactiguard, Rapid Micro Biosystems, Modulight, FluoGuide and SomnoMed.

Most QTREX Quantum public comparables operate across Medical Devices, HealthTech and DeepTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
TELA Bio$80M($32M)1.1x1.1x(2.6x)(2.8x)
Outset Medical$119M($70M)0.1x0.1x(0.2x)(0.3x)
Pangaea Oncology$17M($1M)3.8x3.7x(58.0x)(19.8x)
Theraclion$1M($7M)45.3x-(9.0x)-
K Pharma-($6M)--(8.7x)-
Bactiguard$22M$4M3.1x3.0x16.3x20.9x
Rapid Micro Biosystems$34M($44M)1.8x1.6x(1.3x)(1.4x)
Modulight$8M($343K)5.9x5.7x(141.1x)89.8x

This data is available for Pro users. Sign up to see all QTREX Quantum competitors and their valuation data.

Start Free Trial

Acquisitions by QTREX Quantum

QTREX Quantum has acquired 1 company to date.

Last acquisition by QTREX Quantum was on April 5th 2026. QTREX Quantum acquired Nano Dimension (AME unit) for $13M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by QTREX Quantum

Nano Dimension (AME unit)
Description
Nano Dimension (AME unit) is a multi-material additive manufacturing platform from Israeli 3D printing firm Nano Dimension Ltd. (NASDAQ: NNDM). High-precision inkjet printing produces functional electronics like multi-layer PCBs for aerospace and defense. Printers, inks, and services drive revenue.
HQ CountryIsrael
HQ City
-
Deal Date5 Apr 2026
Valuation$13M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all QTREX Quantum acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About QTREX Quantum

When was QTREX Quantum founded?QTREX Quantum was founded in 2018.
Where is QTREX Quantum headquartered?QTREX Quantum is headquartered in Israel.
How many employees does QTREX Quantum have?As of today, QTREX Quantum has over 47 employees.
Is QTREX Quantum publicly listed?Yes, QTREX Quantum is a public company listed on Nasdaq.
What is the stock symbol of QTREX Quantum?QTREX Quantum trades under QTEX ticker.
When did QTREX Quantum go public?QTREX Quantum went public in 2021.
Who are competitors of QTREX Quantum?QTREX Quantum main competitors include TELA Bio, Outset Medical, Pangaea Oncology, Theraclion, K Pharma, Bactiguard, Rapid Micro Biosystems, Modulight, FluoGuide, SomnoMed.
What is the current market cap of QTREX Quantum?QTREX Quantum's current market cap is $58M.
What is the current revenue of QTREX Quantum?QTREX Quantum's last 12 months revenue is $289K.
What is the current revenue growth of QTREX Quantum?QTREX Quantum revenue growth (NTM/LTM) is 16509%.
What is the current EV/Revenue multiple of QTREX Quantum?Current revenue multiple of QTREX Quantum is 191.5x.
Is QTREX Quantum profitable?No, QTREX Quantum is not profitable.
What is the current EBITDA of QTREX Quantum?QTREX Quantum has negative EBITDA and is not profitable.
What is QTREX Quantum's EBITDA margin?QTREX Quantum's last 12 months EBITDA margin is (3709%).
What is the current EV/EBITDA multiple of QTREX Quantum?Current EBITDA multiple of QTREX Quantum is (5.2x).
How many companies QTREX Quantum has acquired to date?As of September 2026, QTREX Quantum has acquired 1 company.
What was the largest acquisition by QTREX Quantum?$13M acquisition of Nano Dimension (AME unit) on 5th April 2026 was the largest M&A QTREX Quantum has done to date.
What companies QTREX Quantum acquired?QTREX Quantum acquired Nano Dimension (AME unit).
In how many companies QTREX Quantum has invested to date?QTREX Quantum hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to QTREX Quantum

Lists including QTREX Quantum

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial